Alembic Pharmaceuticals Limited has received a certificate from its Registrar and Share Transfer Agent, MUFG Intime India Private Limited (formerly Link Intime India Private Limited), for the quarter ended March 31, 2026. This certificate confirms compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The certificate details that securities received from depository participants for dematerialisation during the specified quarter were processed and confirmed with the depositories. The securities were listed on the stock exchanges as per the existing listings. Furthermore, the security certificates received for dematerialisation were verified, mutilated, cancelled, and the register of members was updated with the depositories as the registered owners within the prescribed timelines. The company has requested the stock exchanges, BSE Limited and the National Stock Exchange of India Ltd., to take this information on record.
